EXAGEN INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
EXAGEN INC. (XGN) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $1.84 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-04
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.84M.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.77M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $944.00K.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.89M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $1.84M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $2.77M 10-Q · filed 2026-05-11 |
| 2025-09-30 | $944.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.89M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-05 |
| 2024-09-30 | $517.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.09M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $1.47M 10-Q · filed 2024-05-13 |
| 2023-09-30 | $487.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $950.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.50M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $420.00K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $837.00K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $1.25M 10-Q · filed 2022-05-11 |
| 2021-09-30 | $446.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $889.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.33M 10-Q · filed 2021-05-11 |
| 2020-09-30 | $437.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $872.00K 10-Q · filed 2020-07-28 |
| 2020-03-31 | $1.30M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $725.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |